Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures-Reference-Cited by-同舟云学术

Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures

Published:2017-12-11 Issue:1 Volume:47 Page:137-137
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Targownik L. E.¹^ORCID

Affiliation:

1. Department of Gastroenterology; University of Manitoba; Winnipeg Manitoba Canada

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14381/fullpdf

Reference7 articles.

1. Proton-pump inhibitors and risk of fractures: an update meta-analysis;Zhou;Osteoporos Int,2016

2. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors;Kaye;Pharmacotherapy,2008

3. Use of proton pump inhibitors and risk of osteoporosis-related fractures;Targownik;CMAJ,2008

4. Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity;Costa-Rodrigues;FEBS J,2013

5. FDA Drug Safety Communication: Possible increased risk of fractures of the hip, https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213206.htm

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013;Zeitschrift für Gastroenterologie;2023-07

2. Konservative Therapie der gastroösophagealen Refluxkrankheit;Gastroösophageale Refluxerkrankung;2023

3. Latest insights into the hot question of proton pump inhibitor safety – a narrative review;Digestive and Liver Disease;2020-08

4. Proton pump inhibitors and fracture risk. The HUNT study, Norway;Osteoporosis International;2019-11-18

5. Letter: association between proton pump inhibitor use and fracture risk - causality or confounding?;Alimentary Pharmacology & Therapeutics;2018-05-17